Monkeypox: EU Commission purchases treatment courses to meet immediate needs
Brussels, 26 September 2022 Today, the Commission has secured over 10,000 treatment courses of tecovirimat...
WHO and EU Commission Statement on preventing monkeypox from becoming endemic
Brussels, 13 September 2022 Today, on the occasion of the 72nd session of the WHO...
Monkeypox outbreak: HERA secures additional vaccine doses
Brussels, 7 September 2022 Today, HERA, the Commission’s Health Emergency Preparedness and Response Authority, has secured an additional...
EU Commissioner Kyriakides on the intradermal use of monkeypox vaccine
Brussels, 19 August 2022 Today, the European Medicines Agency (EMA) has advised on intradermal use of monkeypox...
Teleconference: Press briefing by White House Monkeypox Response Team and Public Health Officials
Washington D.C., 11 August 2022 FENTON: Hi, I’m Bob Fenton, the White House National Response...
WHO: Emergency Committee meets again in light of multi-country Monkeypox outbreak
New York, 21 July 2022 The World Health Organization (WHO) on Thursday reconvened the Monkeypox...
Monkeypox outbreak: ECDC update to Rapid Risk Assessment
The European Centre of Disease Prevention and Control has today released the Rapid Risk Assessment Monkeypox...
ECDC and WHO publish joint technical report on navigating monkeypox
As monkeypox cases rise, the European Centre for Disease Prevention and Control (ECDC) and the...
HERA secures monkeypox vaccines for EU Member states
Brussels, 14 June 2022 Today, HERA, the European Commission’s Health Preparedness and Response Authority, concluded...
ECDC Publishes monkeypox rapid risk assessment and response options
Solna, 23 May 2022 In a Rapid Risk Assessment published today, the European Centre for Disease Prevention...
ECDC alert: Monkeypox cases reported in UK and Portugal
Several cases of monkeypox have been confirmed in Europe, including an EU Member State (Portugal)....